Skip to record
Intellia Therapeutics, Inc.
Enterprise record · Agent view
Version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceLoading machine representation…
Enterprise record · Agent view
Version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ceLoading machine representation…
Agent view
Access the same published Governance Record as Human View.
alpha:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42 · public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
https://registry.alpha.ac/companies/intellia-therapeutics-inc.md
# Intellia Therapeutics, Inc.
> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
## Record
| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/intellia-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 22 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-05T15:31:29.535299+00:00 |
| Last reviewed | 2026-10-05T15:31:29.535299+00:00 |
## Identity
- Legal name: Intellia Therapeutics, Inc.
- Display name: Intellia Therapeutics, Inc.
## Alpha Governance Record
| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-06T03:38:07.283381+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.827 |
| Directors | 12 |
| Committees | 0 |
| Governance events | 7 |
| Entity class | public_company |
## Section coverage
| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |
## Board
- Brian Goff: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:6
- By Mail: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:7
- Frank Verwiel: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-30. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:8
- Jesse Goodman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2018-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:11
- Muna Bhanji: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2022-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:14
- William Chase: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2023-01-01. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:16
- Frank Verwiel, M.D.: Chairperson of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:5
- Fred Cohen, M.D., D.Phil.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:9
- Georgia Keresty, Ph.D., M.P.H.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:10
- Jesse Goodman, M.D., M.P.H.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:12
- John M. Leonard, M.D.: President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:13
- Muna Bhanji, R.Ph.: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:15
## Executive leadership
- Bradley T. Sheares, Ph.D.: Named Executive Officer. Status: current. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:18
- Birgit Schultes, Ph.D.: Executive Vice President, Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:17
- David Lebwohl, M.D.: Executive Vice President, Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:19
- Edward J. Dulac III: Executive Vice President, Chief Financial Officer and Treasurer [CFO]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:20
- James Basta, J.D.: Executive Vice President, General Counsel and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:21
- John M. Leonard, M.D.: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:22
## Governance events
- DIRECTOR_APPOINTED: Brian Goff seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:7lnbgg
- DIRECTOR_APPOINTED: By Mail seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1nfu16z
- DIRECTOR_APPOINTED: Frank Verwiel seat on Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1f0nveu
- EXECUTIVE_APPOINTED: Bradley T. Sheares, Ph.D. executive of Intellia Therapeutics, Inc., effective 2026-04-30. Effective: 2026-04-30. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:executive_appointed:aw2oue
- DIRECTOR_APPOINTED: William Chase seat on Intellia Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1qqptoe
- DIRECTOR_APPOINTED: Muna Bhanji seat on Intellia Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:1887745
- DIRECTOR_APPOINTED: Jesse Goodman seat on Intellia Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-05T15:31:29.535299+00:00. event_id=alpha:event:director_appointed:ef2ubd
## Scoped resources
- `alpha://company/intellia-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record
- `alpha://company/intellia-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=identity
- `alpha://company/intellia-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=corporate-structure
- `alpha://company/intellia-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=board
- `alpha://company/intellia-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=committees
- `alpha://company/intellia-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=leadership
- `alpha://company/intellia-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ownership
- `alpha://company/intellia-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=financials
- `alpha://company/intellia-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=capital-structure
- `alpha://company/intellia-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=compensation
- `alpha://company/intellia-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=governance
- `alpha://company/intellia-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=shareholder-governance
- `alpha://company/intellia-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=audit
- `alpha://company/intellia-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=legal
- `alpha://company/intellia-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=risk
- `alpha://company/intellia-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=cyber
- `alpha://company/intellia-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ai-governance
- `alpha://company/intellia-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=agents
- `alpha://company/intellia-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=ecosystem
- `alpha://company/intellia-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=events
- `alpha://company/intellia-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=relationships
- `alpha://company/intellia-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=assessments
- `alpha://company/intellia-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record§ion=evidence
## Role modules
- NOT_ASSERTED
## Attention
- NO_RECORDS_FOUND
## Committee data
- NO_RECORDS_FOUND
## Leadership
- Frank Verwiel, M.D.: Chairperson of the Board. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Brian Goff: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:6. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- By Mail: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:7. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- Frank Verwiel: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:8. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- Fred Cohen, M.D., D.Phil.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Georgia Keresty, Ph.D., M.P.H.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Jesse Goodman: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- Jesse Goodman, M.D., M.P.H.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- John M. Leonard, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Muna Bhanji: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:14. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- Muna Bhanji, R.Ph.: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- William Chase: Director. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:16. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f.
- Birgit Schultes, Ph.D.: Executive Vice President, Chief Scientific Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Bradley T. Sheares, Ph.D.: Named Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:18. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:d803c5efef632f1e8319f272449efc903a6351aa4d50b90487317a005dddc5f5.
- David Lebwohl, M.D.: Executive Vice President, Chief Medical Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- Edward J. Dulac III: Executive Vice President, Chief Financial Officer and Treasurer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- James Basta, J.D.: Executive Vice President, General Counsel and Corporate Secretary. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
- John M. Leonard, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9.
## Roles
- PUBLISHED
## Governance
- NOT_ASSERTED
## Board committees
- PUBLISHED
## Financials
- NOT_ASSERTED
## Workforce
- NOT_ASSERTED
## Market and index context
- PUBLISHED
## Legal Name
- Intellia Therapeutics, Inc.. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b.
## Entity Status
- Public listing published. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b.
## Published Fact
- US. Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b.
## Security Listing
- NTLA (NASDAQ). Claim: alpha:claim:company:61b74e87-6dde-4a9c-8a56-7acdd43e3f42:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b.
## Coverage states
| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
## Public sources
- alpha:projection-evidence:894ac2be61d2d127e058632b4d8331b96d3b38908ecab0e824ad55157fde842b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/intellia-therapeutics-inc).
- alpha:projection-evidence:document:4359dbb6e153ed540d051aec4374f8b82e01d4706b9b51eaeaad927a9a063ed9: [SEC DEF 14A 0001193125-26-197283](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm).
- alpha:projection-evidence:document:0cd00322efde432d005ec4eb264d3a50c2a8e75c5234578152bd4b963033428f: [DEF 14A ntla-20260430.htm](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm).
- alpha:projection-evidence:document:d803c5efef632f1e8319f272449efc903a6351aa4d50b90487317a005dddc5f5: [NTLA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1652130/000119312526197283/ntla-20260430.htm).
## Rights
| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
## Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
## Alternate representations
- [Canonical profile](https://registry.alpha.ac/companies/intellia-therapeutics-inc)
- [Public Markdown](https://registry.alpha.ac/companies/intellia-therapeutics-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/intellia-therapeutics-inc?format=jsonld)
- MCP resource: `alpha://companies/intellia-therapeutics-inc` at https://mcp.alpha.ac/mcp
## Connected governance records
Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.
## Critical-risk oversight
Snapshot as of 2026-10-06T03:38:07.295836+00:00; recorded 2026-10-06T03:38:07.295836+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.Server card: Alpha Terminal · alpha://companies/intellia-therapeutics-inc
find_personSearch Alpha's permission-safe public Profile directory. Returns canonical Alpha person IDs, evidence-backed current roles, assurance state, review time, and limitations. Similar names remain separate candidates.
get_claim_evidenceRetrieve the public source evidence for one permissioned Alpha Profile claim. Returns source tier, URLs, validity, confidence, review time, and limitations.
get_company_profileRetrieve a public Alpha Company Profile with canonical company identity, active listings, current confirmed board and executive roles, source evidence, explicit permissions, as-of time, and limitations. Private relationships, company administration, and unpublished ratings are excluded.
get_current_rolesRetrieve the current confirmed company and board roles from a public Alpha Profile. Every role includes available source evidence, confidence, verification state, and validity.
get_executive_profileRetrieve a public Alpha Profile with canonical identity, current verified roles, permissioned claims, claim-level evidence, assurance state, as-of time, and limitations. Private contact, Council activity, and relationships are excluded.
get_platform_statsGet Alpha platform statistics and data coverage. Returns counts of companies, directors, ratings, filings, and regulations in the Alpha intelligence database.
Recent Registry updates (general index)
Record-specific feeds and webhooks: Proposed. No delivery endpoint is published.
Published Claims assembled into typed sections. Scoped HTTP and MCP resource contracts appear below.
HTTP resources are live. Check the MCP server card for supported resources; a published URI does not establish availability.